A randomized, open label, 4 period crossover study in healthy subjects to determine the effect of particle size on the pharmacokinetics of a single mg dose of GW856553.
Phase of Trial: Phase I
Latest Information Update: 12 Mar 2010
At a glance
- Drugs Losmapimod (Primary)
- Indications Atherosclerosis; Chronic obstructive pulmonary disease; Depressive disorders; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline
- 31 Aug 2018 Biomarkers information updated
- 12 Mar 2010 Last checked against ClinicalTrials.gov record.
- 28 Aug 2007 New trial record.